Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

1.

Neuronal LRP1 Regulates Glucose Metabolism and Insulin Signaling in the Brain.

Liu CC, Hu J, Tsai CW, Yue M, Melrose HL, Kanekiyo T, Bu G.

J Neurosci. 2015 Apr 8;35(14):5851-9. doi: 10.1523/JNEUROSCI.5180-14.2015.

PMID:
25855193
2.

Blood methylomic signatures of presymptomatic dementia in elderly subjects with type 2 diabetes mellitus.

Lunnon K, Smith RG, Cooper I, Greenbaum L, Mill J, Beeri MS.

Neurobiol Aging. 2015 Mar;36(3):1600.e1-4. doi: 10.1016/j.neurobiolaging.2014.12.023. Epub 2014 Dec 24.

PMID:
25585531
3.

Type 2 diabetes mellitus and Alzheimer's disease.

Barbagallo M, Dominguez LJ.

World J Diabetes. 2014 Dec 15;5(6):889-93. doi: 10.4239/wjd.v5.i6.889. Review.

4.

Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.

Kapogiannis D, Boxer A, Schwartz JB, Abner EL, Biragyn A, Masharani U, Frassetto L, Petersen RC, Miller BL, Goetzl EJ.

FASEB J. 2015 Feb;29(2):589-96. doi: 10.1096/fj.14-262048. Epub 2014 Oct 23.

PMID:
25342129
5.

Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease.

Proitsi P, Lupton MK, Velayudhan L, Hunter G, Newhouse S, Lin K, Fogh I, Tsolaki M, Daniilidou M, Pritchard M, Craig D, Todd S, Johnston JA, McGuinness B, Kloszewska I, Soininen H, Mecocci P, Vellas B, Passmore PA, Sims R, Williams J, Brayne C; Alzheimer's Disease Neuroimaging Initiative; GERAD1 Consortium, Stewart R, Sham P, Lovestone S, Powell JF.

Neurobiol Aging. 2014 Dec;35(12):2883.e3-2883.e10. doi: 10.1016/j.neurobiolaging.2014.07.023. Epub 2014 Jul 24.

PMID:
25150574
6.

[Mechanisms of the immune system ageing and some age-associated diseases].

Witkowski JM.

Postepy Biochem. 2014;60(2):233-9. Review. Polish.

PMID:
25134358
7.

Type 2 diabetes as a risk factor for cognitive impairment: current insights.

Umegaki H.

Clin Interv Aging. 2014 Jun 28;9:1011-9. doi: 10.2147/CIA.S48926. eCollection 2014. Review.

8.

Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women.

Winkler A, Dlugaj M, Weimar C, Jöckel KH, Erbel R, Dragano N, Moebus S.

J Alzheimers Dis. 2014;42(4):1269-77. doi: 10.3233/JAD-140696.

PMID:
25024326
9.

Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Butterfield DA, Di Domenico F, Barone E.

Biochim Biophys Acta. 2014 Sep;1842(9):1693-706. doi: 10.1016/j.bbadis.2014.06.010. Epub 2014 Jun 17. Review.

PMID:
24949886
10.

Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease.

Yarchoan M, Arnold SE.

Diabetes. 2014 Jul;63(7):2253-61. doi: 10.2337/db14-0287. Epub 2014 Jun 15. Review.

11.

Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?

Biessels GJ, Reijmer YD.

Diabetes. 2014 Jul;63(7):2244-52. doi: 10.2337/db14-0348. Epub 2014 Jun 15. Review.

12.

Obesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia.

Niedowicz DM, Reeves VL, Platt TL, Kohler K, Beckett TL, Powell DK, Lee TL, Sexton TR, Song ES, Brewer LD, Latimer CS, Kraner SD, Larson KL, Ozcan S, Norris CM, Hersh LB, Porter NM, Wilcock DM, Murphy MP.

Acta Neuropathol Commun. 2014 Jun 10;2:64. doi: 10.1186/2051-5960-2-64.

13.

Impaired glycemia and Alzheimer's disease.

Morris JK, Vidoni ED, Honea RA, Burns JM.

Neurobiol Aging. 2014 Oct;35(10):e23. doi: 10.1016/j.neurobiolaging.2014.04.018. Epub 2014 Apr 26. No abstract available.

PMID:
24889040
14.

Impaired glycemia and Alzheimer's disease.

Umegaki H.

Neurobiol Aging. 2014 Oct;35(10):e21. doi: 10.1016/j.neurobiolaging.2014.04.017. Epub 2014 Apr 26. No abstract available.

PMID:
24854798
15.

Cellular senescence and the senescent secretory phenotype in age-related chronic diseases.

Zhu Y, Armstrong JL, Tchkonia T, Kirkland JL.

Curr Opin Clin Nutr Metab Care. 2014 Jul;17(4):324-8. doi: 10.1097/MCO.0000000000000065. Review.

PMID:
24848532
16.

Brain imaging in type 2 diabetes.

Brundel M, Kappelle LJ, Biessels GJ.

Eur Neuropsychopharmacol. 2014 Dec;24(12):1967-81. doi: 10.1016/j.euroneuro.2014.01.023. Epub 2014 Mar 15.

PMID:
24726582
17.

Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation.

Roberts RO, Knopman DS, Cha RH, Mielke MM, Pankratz VS, Boeve BF, Kantarci K, Geda YE, Jack CR Jr, Petersen RC, Lowe VJ.

J Nucl Med. 2014 May;55(5):759-64. doi: 10.2967/jnumed.113.132647. Epub 2014 Mar 20.

18.

The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging.

Marano CM, Workman CI, Lyman CH, Kramer E, Hermann CR, Ma Y, Dhawan V, Chaly T, Eidelberg D, Smith GS.

Psychiatry Res. 2014 Apr 30;222(1-2):84-90. doi: 10.1016/j.pscychresns.2014.01.009. Epub 2014 Feb 1.

19.

Non-viability of crossing the Alzheimer mouse model Tg2576 with the type 2 diabetes mouse model ob/ob.

Lubitz I, Haroutunian V, Katsel P, Leroith D, Landa N, Castel D, Shaish A, Shnerb R, Schnaider-Beeri M.

Neurobiol Aging. 2014 Jul;35(7):e19-20. doi: 10.1016/j.neurobiolaging.2014.01.138. Epub 2014 Jan 31. No abstract available.

PMID:
24581479
20.

The paradox of neuronal insulin action and resistance in the development of aging-associated diseases.

Steculorum SM, Solas M, Brüning JC.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S3-11. doi: 10.1016/j.jalz.2013.12.008. Review.

PMID:
24529522
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk